Begin main content

Reports

We found 5312 result(s)

Teriparatide (rDNA origin) injection (Forteo)

Last Updated: June 8, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Teriparatide (rDNA origin) injection
Indications: Osteoporosis

  • Brand Name: Forteo
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: S0015
  • Project Status: Complete
  • Submission Type: New

Pegfilgrastim (Neulasta)

Last Updated: March 29, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Pegfilgrastim
Indications: Neutropenia

  • Brand Name: Neulasta
  • Manufacturer: Amgen Canada Inc.
  • Project Number: S0009
  • Project Status: Complete
  • Submission Type: New

Adalimumab (Humira)

Last Updated: September 24, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Adalimumab
Indications: Arthritis, Rheumatoid

  • Brand Name: Humira
  • Manufacturer: Abbott Laboratories Limited
  • Project Number: S0022
  • Project Status: Complete
  • Submission Type: New

Mycophenolate sodium (Myfortic)

Last Updated: March 3, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Mycophenolate sodium
Indications: Organ rejection in allogeneic renal transplants, Prophylaxis

  • Brand Name: Myfortic
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: S0034
  • Project Status: Complete
  • Submission Type: New

Drospirenone /ethinyl estradiol (Yasmin)

Last Updated: January 20, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Drospirenone /ethinyl estradiol
Indications: Contraceptive, oral

  • Brand Name: Yasmin
  • Manufacturer: Berlex Canada Inc.
  • Project Number: S0029
  • Project Status: Complete
  • Submission Type: New

Quinagolide hydrochloride (Norprolac)

Last Updated: November 23, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Quinagolide hydrochloride
Indications: Hyperprolactinemia

  • Brand Name: Norprolac
  • Manufacturer: Ferring Pharmaceuticals
  • Project Number: S0046
  • Project Status: Complete
  • Submission Type: Resubmission

Insulin aspart/insulin aspart protamine (NovoMix 30)

Last Updated: October 13, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Insulin aspart/insulin aspart protamine
Indications: Diabetes mellitus

  • Brand Name: NovoMix 30
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: S0041
  • Project Status: Complete
  • Submission Type: New